N-Substituted (Benzoimidazol-2-yl)phenylamines, Processes for Their Preparation, Their Use as a Medicament or Diagnostic Aid, and a Medicament Comprising Them

A compound of formula I

• wherein,
• R1 and R4 are independently selected from the group consisting of H, F, Cl, Br, C1-C4-alkyl and C1-C4-alkoxy wherein, the C1-C4-alkyl and C1-C4-alkoxy are optionally substituted independently of one another by 1, 2, 3, 4, 5, 6, 7, 8 or 9 fluorine atoms;
• R2 and R3 are independently selected from the group consisting of H, F, OH, C1-C3-alkyl, and C1-C3-alkoxy wherein, the C1-C3-alkyl and C1-C3-alkoxy are optionally substituted independently of one another by 1, 2, 3, 4, 5, 6 or 7 fluorine atoms;
• R5 is independently selected from the group consisting of C1-C4-alkyl, C2-C4-alkenyl and C3-C5-cycloalkyl, wherein, the C1-C4-alkyl, C2-C4-alkenyl and C3-C5-cycloalkyl are optionally substituted by 1, 2, 3, 4, 5, 6, 7, 8 or 9 fluorine atoms;
• and
• R6 and R7 are independently selected from the group consisting of H, F, Cl, Br, C1-C4-alkyl and C1-C3-alkoxy, wherein, the C1-C4-alkyl and C1-C3-alkoxy are optionally substituted independently of one another by 1, 2, 3, 4, 5, 6, 7, 8 or 9 fluorine atoms,
• provided that R6 and R7 are not simultaneously hydrogen;
• or the pharmaceutically acceptable salt, or trifluoroacetic acid salt thereof.